Moreover, autopsy samples of bone marrow obtained from prostate cancer and lung cancer patients who died from bone metastases expressed higher levels of CRLR, compared with those obtained from non-bone metastatic prostate cancer and lung cancer patients that died because of other reasons (Fig 6E–G). This evidence concerns the gene CALCRL and prostate carcinoma.